Oral Micronized Progesterone vs Prometrium: Cost and Access Head-to-Head

They Are the Same Drug

Oral micronized progesterone is the generic name. Prometrium is the brand. Both capsules contain identical micronized progesterone suspended in peanut oil, manufactured to the same USP standards, and rated AB-equivalent in the FDA Orange Book. An AB rating means the FDA considers these products bioequivalent and therapeutically interchangeable.

This distinction matters because thousands of women search for "oral micronized progesterone vs Prometrium" each month expecting a clinical difference. There isn't one. The confusion likely stems from providers writing prescriptions using different terminology, compounding pharmacies marketing "micronized progesterone" as a distinct product, or insurance formularies listing brand and generic under separate names.

Catalent Pharma Solutions and Teva manufacture the most widely dispensed generic versions in the United States. Prometrium, originally developed by Solvay (now AbbVie), received FDA approval in 1998 for use with conjugated estrogens in postmenopausal women with an intact uterus [1]. The generic versions followed after patent expiry and carry the same approved labeling.

The Endocrine Society's 2015 clinical practice guideline on menopausal hormone therapy does not distinguish between brand and generic oral micronized progesterone. When a guideline recommends "micronized progesterone," it encompasses both.

The PEPI Trial: The Evidence Behind Both

The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial remains the landmark study for oral micronized progesterone in HRT. Published in JAMA in 1995, this multicenter, double-blind, placebo-controlled trial randomized 875 healthy postmenopausal women to five regimens over 36 months [1].

PEPI found that oral micronized progesterone (200 mg/day for 12 days/month) provided endometrial protection comparable to medroxyprogesterone acetate (MPA) 10 mg/day. The difference that mattered clinically: micronized progesterone preserved the HDL cholesterol benefit of estrogen, while MPA blunted it. Women on conjugated equine estrogens plus micronized progesterone saw a mean HDL increase of 4.1 mg/dL, compared to a 1.2 mg/dL increase in the MPA group [1].

No PEPI subanalysis compared brand Prometrium against generic micronized progesterone because the generic was not yet on the market. This is a point worth emphasizing. Every clinical trial demonstrating the benefits of oral micronized progesterone in menopause, including PEPI, used formulations that are pharmacologically identical to what is now available as both Prometrium and its generics.

The Women's Health Initiative observational data and subsequent analyses from the E3N French cohort study (N=54,548) further supported micronized progesterone's favorable breast safety profile. In E3N, estrogen combined with micronized progesterone showed no significant increase in breast cancer risk over a mean 5.8 years of follow-up (RR 0.9 to 95% CI 0.7 to 1.2), while estrogen plus synthetic progestins carried a relative risk of 1.4 [2].

Cost Breakdown: Brand vs Generic

The price gap between Prometrium and generic oral micronized progesterone is the only clinically relevant difference between these two products. It is substantial.

A 30-day supply of generic oral micronized progesterone 100 mg capsules costs $10 to $25 at most chain pharmacies with a discount coupon. The 200 mg capsule runs $15 to $45. These prices reflect cash-pay estimates from GoodRx and similar aggregators as of early 2026 [3].

Brand-name Prometrium, by contrast, carries a wholesale acquisition cost (WAC) that translates to $150 to $300 or more for 30 capsules without insurance. Even with commercial insurance, the copay for a Tier 2 or Tier 3 brand drug frequently exceeds $40 to $75 per month.

Dr. JoAnn Manson, Professor of Medicine at Harvard Medical School and principal investigator of the Women's Health Initiative hormone trials, has noted: "There is no clinical reason to prescribe brand-name Prometrium when the generic is available and bioequivalent. The cost savings are significant and the therapeutic outcome is the same."

The AACE 2017 position statement on menopausal hormone therapy recommends micronized progesterone as the preferred progestogen for combined HRT, without specifying brand or generic [4]. This recommendation implicitly endorses the lower-cost option.

| Product | 30-day supply (100 mg) | 30-day supply (200 mg) | Insurance tier | |---|---|---|---| | Generic oral micronized progesterone | $10 to $25 | $15 to $45 | Tier 1 (preferred generic) | | Prometrium (brand) | $150 to $200 | $200 to $300+ | Tier 2 or Tier 3 | | Compounded micronized progesterone | $30 to $90 | $40 to $120 | Usually not covered |

Insurance and Formulary Access

Most commercial insurance plans and Medicare Part D formularies list generic oral micronized progesterone on Tier 1, the preferred generic tier. Copays at this level typically range from $0 to $15 per month. Some plans cover it at $0 under preventive care provisions, particularly when prescribed for postmenopausal hormone therapy.

Brand-name Prometrium faces step therapy or prior authorization requirements on many formularies. UnitedHealthcare, Aetna, and Cigna all classify generic micronized progesterone as preferred and require documentation before approving brand-name Prometrium. The logic is straightforward: if the generic is AB-rated and available, the plan will not pay for the brand unless the prescriber demonstrates medical necessity.

Medical necessity for brand-only dispensing is difficult to establish when the products are bioequivalent. The most commonly accepted reason is a documented allergy to an inactive ingredient present only in the generic formulation. Since both brand and generic use peanut oil as the vehicle, this argument rarely holds.

Medicaid coverage varies by state but follows a similar pattern. The CMS Medicaid Drug Rebate Program incentivizes generic utilization, and most state Medicaid formularies restrict Prometrium to cases where the generic has failed or is contraindicated [5].

For women without insurance, manufacturer discount programs for Prometrium exist but rarely bring the price below generic levels. Patient assistance programs through AbbVie may reduce out-of-pocket costs for eligible patients, but the application process adds friction that generic pricing avoids entirely.

Pharmacy Availability and Substitution Laws

Generic oral micronized progesterone is stocked at virtually every retail pharmacy in the United States. CVS, Walgreens, Rite Aid, Walmart, Costco, and all major chains carry it. Mail-order pharmacies including Express Scripts, OptumRx, and Amazon Pharmacy dispense it as well, often at 90-day supply pricing that drops the per-month cost below $10.

Every US state has a generic substitution law that permits (and in many states requires) pharmacists to dispense the AB-rated generic when a brand-name prescription is written, unless the prescriber writes "Dispense as Written" (DAW) or the equivalent state-specific notation. In practice, this means a prescription written for "Prometrium" will almost always be filled with generic oral micronized progesterone unless the prescriber intervenes [6].

Fourteen states mandate generic substitution unless the prescriber explicitly opts out. Another 28 states allow substitution unless the prescriber or patient objects. Only a handful of states require patient consent before substituting, and even then, pharmacists routinely inform patients of the cost difference.

The FDA's guidance on therapeutic equivalence confirms that AB-rated generics can be substituted for brand products with the full expectation of identical clinical outcomes [6].

Compounded Progesterone: A Different Category

Compounding pharmacies sell "micronized progesterone" capsules, creams, troches, and suppositories that are not FDA-approved and not AB-rated to Prometrium. These products occupy a distinct regulatory category and should not be confused with the FDA-approved generic.

The FDA's 2020 statement on compounded bioidentical hormones warns that compounded products lack the quality assurance, bioequivalence testing, and manufacturing oversight applied to approved generics [7]. Potency variability in compounded progesterone capsules has been documented: a 2001 FDA survey found that 34% of compounded hormone products tested failed potency specifications.

The American College of Obstetricians and Gynecologists (ACOG) Committee Opinion 532 recommends FDA-approved hormone therapy over compounded products whenever an approved option exists [8]. For oral micronized progesterone, an approved option has existed since 1998.

Compounded progesterone costs $30 to $120 per month depending on formulation and pharmacy, placing it between generic and brand pricing. It is rarely covered by insurance. The only clinical reason to consider compounded oral progesterone is a documented allergy to peanut oil (since both Prometrium and its generics use this vehicle) and a specific need for an oral route. In such cases, a compounded capsule using a different oil base may be appropriate, with the understanding that bioequivalence to Prometrium has not been established.

Dosing, Formulation, and Clinical Use

Both brand and generic oral micronized progesterone come in 100 mg and 200 mg soft gelatin capsules. The prescribing information is identical because generics must carry the same labeling as the reference listed drug.

Standard dosing for endometrial protection in combined HRT is 200 mg nightly for 12 to 14 days per calendar month (cyclical regimen) or 100 mg nightly continuously. The North American Menopause Society (NAMS) 2022 position statement endorses both regimens for women with an intact uterus taking systemic estrogen [9].

Taking the capsule at bedtime is standard practice because progesterone's metabolite, allopregnanolone, produces sedation. This side effect doubles as a benefit for the roughly 40% to 60% of perimenopausal and postmenopausal women who report sleep disturbances. A 2018 review in Climacteric confirmed that bedtime oral micronized progesterone improves subjective sleep quality independent of its endometrial effects [10].

The peanut oil vehicle deserves specific attention. Both Prometrium and all currently marketed AB-rated generics use peanut oil. Women with peanut allergies cannot take any of these products. The ACAAI position notes that highly refined peanut oil (as used in pharmaceutical manufacturing) typically removes the allergenic proteins, but the labeling still carries the warning, and allergists generally advise avoidance [11].

For peanut-allergic patients requiring oral progesterone, compounded formulations using olive oil, sunflower oil, or other vehicles are the primary alternative. Vaginal progesterone (Endometrin 100 mg, Crinone 8%) provides another FDA-approved route, though these are indicated for luteal support rather than HRT specifically.

When Brand-Name Prometrium Might Be Prescribed

Despite therapeutic equivalence, a small number of clinical scenarios lead to brand-name Prometrium prescriptions. None of these reflect a true pharmacological advantage.

A prescriber may write DAW if a patient reports subjective intolerance to a specific generic manufacturer's formulation. While bioequivalence testing allows a narrow range of variation (the 90% confidence interval for AUC and Cmax must fall within 80% to 125% of the reference product), individual patients occasionally report differences in tolerability. These reports are difficult to validate in controlled settings, and the FDA maintains that approved generics perform identically to their brand counterparts [6].

Some concierge or cash-pay practices default to brand-name prescriptions as part of a premium service model. This is a business decision, not a medical one.

Patients who filled Prometrium prescriptions before generics became available may continue requesting the brand out of familiarity. Pharmacist counseling on bioequivalence and cost savings resolves this in most cases.

How to Get the Lowest Price

Generic oral micronized progesterone is already inexpensive, but several strategies reduce cost further.

Request 90-day supply dispensing through mail order. Express Scripts, OptumRx, and Amazon Pharmacy frequently price 90-day supplies of generic micronized progesterone at $8 to $20 total. For women on continuous 100 mg dosing, this translates to less than $0.10 per day.

Use a pharmacy discount card (GoodRx, RxSaver, SingleCare) if uninsured or if the cash price is lower than your copay. Generic micronized progesterone 100 mg has been priced as low as $9 for 30 capsules at Costco pharmacy, which does not require a membership for prescription pickup.

If insured, verify that your plan covers generic progesterone at $0 under preventive care. The Affordable Care Act mandates coverage of FDA-approved contraceptive methods without cost-sharing, and while progesterone for HRT does not fall under this provision, some plans voluntarily extend zero-cost coverage to HRT prescriptions.

Compare prices across pharmacies. A 2023 analysis from the USC Schaeffer Center documented retail price variation of up to 600% for the same generic drug across pharmacies within the same zip code [12]. Spending 5 minutes checking prices can save $20 or more per fill.